NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Munafa technical analysis Halozyme Therapeutics, Inc. HALO technical analysis buy or sell

Munafa technical analysis Halozyme Therapeutics, Inc. HALO technical analysis buy or sell Analysis of Halozyme Therapeutics, Inc. HALO to buy or sell for Daily, weekly or monthly

Quick Chart Bull Charts Forecast Tomorrow Price Targets View Analysis

Halozyme Therapeutics, Inc. HALO Daily Analysis to buy or sell

As per my analysis of Halozyme Therapeutics, Inc. HALO, 12 day returns for Halozyme Therapeutics, Inc. HALO have been positive, with total returns of 9.94, which is 13.94% with investment starting at 71.29.
An investment of 100,000 bucks in Halozyme Therapeutics, Inc. would have become 113940 bucks today.

Halozyme Therapeutics, Inc. HALO moves in a range of 1.3 points on a day to day basis. This means that a total of approx 1.3 plus points of returns can be expected in a bullish day, and a total of 1.3 minus points can be expected in a bearish day.
This is about 1.6% of returns per day.

Halozyme Therapeutics, Inc. Munafa analysis, looking for Trend and BUY or SELL opportunities.

Stock is in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Halozyme Therapeutics, Inc. HALO at this time.

It appears as if Halozyme Therapeutics, Inc. HALO gave a large move recently.

Stock of Halozyme Therapeutics, Inc. (HALO) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might move higher!

Although my analysis for Halozyme Therapeutics, Inc. is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 79.8, for a target of 76.1 or 73.08

You can find more Price Targets here or Forecast here for Shortterm, Midterm, and Longterm

Daily Candle Stick analysis of Halozyme Therapeutics, Inc. HALO

Candle stick analysis of Halozyme Therapeutics, Inc. as on 06 Fri Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 3.3 HC: 0.2 LC: 3.1 OC: 3

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 05 Thu Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 2.5 HC: 1.2 LC: 1.2 OC: 2.5

Candle stick analysis of Halozyme Therapeutics, Inc. as on 04 Wed Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 2.8 HC: 0.4 LC: 2.4 OC: 1.3

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 03 Tue Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 3.9 HC: 0.9 LC: 3 OC: 3.2

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 02 Mon Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 4.6 HC: 0 LC: 4.5 OC: 3.4

Halozyme Therapeutics, Inc. is moving towards a high expiry

Halozyme Therapeutics, Inc. HALO Weekly Analysis to buy or sell

As per my analysis of Halozyme Therapeutics, Inc. HALO, 12 week returns for Halozyme Therapeutics, Inc. HALO have been positive, with total returns of 10.89, which is 15.48% with investment starting at 70.34.
An investment of 100,000 bucks in Halozyme Therapeutics, Inc. would have become 115480 bucks today.

Halozyme Therapeutics, Inc. HALO moves in a range of 3 points on a week to week basis. This means that a total of approx 3 plus points of returns can be expected in a bullish week, and a total of 3 minus points can be expected in a bearish week.
This is about 3.69% of returns per week.

Weekly Candle Stick analysis of Halozyme Therapeutics, Inc. HALO

Candle stick analysis of Halozyme Therapeutics, Inc. as on 06 Fri Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 14.2 HC: 0.2 LC: 14.1 OC: 13

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 30 Fri Jan 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 8.2 HC: 3.9 LC: 4.2 OC: 7.9

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 23 Fri Jan 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 4.7 HC: 4.5 LC: 0.2 OC: 3.2

Halozyme Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 16 Fri Jan 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 4.7 HC: 4 LC: 0.7 OC: 2.5

Halozyme Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 09 Fri Jan 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 9.3 HC: 4.3 LC: 4.8 OC: 7

Halozyme Therapeutics, Inc. is moving towards a high expiry

Halozyme Therapeutics, Inc. HALO Monthly Analysis to buy or sell

As per my analysis of Halozyme Therapeutics, Inc. HALO, 12 month returns for Halozyme Therapeutics, Inc. HALO have been positive, with total returns of 17.39, which is 27.24% with investment starting at 63.84.
An investment of 100,000 bucks in Halozyme Therapeutics, Inc. would have become 127240 bucks today.

Halozyme Therapeutics, Inc. HALO moves in a range of 5.5 points on a month to month basis. This means that a total of approx 5.5 plus points of returns can be expected in a bullish month, and a total of 5.5 minus points can be expected in a bearish month.
This is about 6.77% of returns per month.

Monthly Candle Stick analysis of Halozyme Therapeutics, Inc. HALO

Candle stick analysis of Halozyme Therapeutics, Inc. as on 06 Fri Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 14.2 HC: 0.2 LC: 14.1 OC: 13

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 30 Fri Jan 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 12.8 HC: 5.4 LC: 7 OC: 10.2

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 26 Fri Dec 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 17.9 HC: 4.5 LC: 12.8 OC: 0

Halozyme Therapeutics, Inc. is moving towards a high expiry

Halozyme Therapeutics, Inc. is forming a DOJI candle

Candle stick analysis of Halozyme Therapeutics, Inc. as on 28 Fri Nov 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 14.2 HC: 4 LC: 9.9 OC: 9.8

Halozyme Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Halozyme Therapeutics, Inc. as on 31 Fri Oct 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Halozyme Therapeutics, Inc. are:
HL: 19.6 HC: 17 LC: 2.2 OC: 3.5

Halozyme Therapeutics, Inc. is moving towards a low expiry

Share on: WhatsApp Facebook Tweet